DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

被引：0
作者：
Toffanin, S. [1 ,2 ]
Cabellos, L. [1 ]
Dong, H. [1 ]
Alsinet, C. [3 ]
Harrington, A. [1 ]
Cornella, H. [3 ]
Reddy, R. V. [4 ]
Reddy, P. M. [4 ]
Llovet, J. M. [1 ,3 ,5 ]
机构：
[1] Mt Sinai Sch Med, Div Liver Dis, Liver Canc Program, New York, NY USA
[2] Fdn IRCCS, Ist Nazl Tumori, Dept Surg & Expt Oncol, Hepatooncol Grp, Milan, Italy
[3] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, HCC Translat Res Lab,Hosp Clin,IDIBAPS, Barcelona Clin Liver Canc Grp BCLC,Liver Unit, Barcelona, Spain
[4] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA
[5] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)61093-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1092
引用
收藏
页码：S446 / S447
页数：2
相关论文
共 50 条
  • [31] The role of mTOR inhibitors in the treatment of hepatocellular carcinoma
    Huang, Yi-Hsiang
    Lin, Han-Chieh
    LIVER INTERNATIONAL, 2013, 33 (08) : 1133 - 1134
  • [32] Histone deacetylase inhibitors for treatment of hepatocellular carcinoma
    Danila Coradini
    Annalisa Speranza
    Acta Pharmacologica Sinica, 2005, 26 : 1025 - 1033
  • [33] Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma (vol 14, 1097277, 2023)
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Discovery and characterization of two novel drivers of hepatocellular carcinoma
    Feddersen, Charlotte R.
    Dupuy, Adam J.
    CANCER RESEARCH, 2016, 76
  • [35] Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib
    Decraecker, Marie
    Toulouse, Caroline
    Blanc, Jean-Frederic
    CANCERS, 2021, 13 (24)
  • [36] Progress in the discovery of kinase inhibitors for treatment of parasitic diseases
    Rotella, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [37] The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lien, Han-Chung
    Peng, Yen-Chun
    Tung, Chun-Fang
    Lee, Teng-Yu
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [38] Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment
    Min, Wenjian
    Wang, Yanyin
    Shen, Hongtao
    Zheng, Mingming
    Tong, Chen
    Shen, Hao
    Wang, Dawei
    Zhu, Yasheng
    Wang, Xiao
    Xiao, Yibei
    Zhang, Xiao-Yu
    Yang, Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [39] Kinase inhibitors in the treatment of renal cell carcinoma
    Larkin, James M. G.
    Eisen, Tim
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (03) : 216 - 226
  • [40] Discovery of novel small molecule Mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia
    Wang, Xiaodong
    Liu, Jing
    Yang, Chao
    Simpson, Catherine
    Deusen, Amy
    Norris-Drouin, Jacqueline
    Janzen, William
    Kireev, Dmitri
    Frye, Stephen
    DeRychere, Deborah
    Graham, Doug
    Hunter, Debra
    Earp, H. Shelton
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345